Phenomix Raises $55M Series C

San Diego-based Phenomix, a company developing therapeutics for the treatment of type 2 diabetes, hepatitis C, and other diseases, said today that it has closed on $55M in a Series C funding. The funding was led by Nomura Phase4 Ventures, and also included existing investors JP Morgan Partners, Delphi Ventures, Baker Brothers, Alta Partners, Sofinnova Ventures, Bay City Capital, CMEA Ventures, Novartis BioVenture Fund and GBS Venture Partners. The funding will go towards clinical development of the firm's therapeutics. More information »